Ligand Pharmaceuticals Inc (LGND)
Operating Cash Flow (Statement)
$131.64M
TTM · Period ending: · USD
LGND Operating Cash Flow (Statement)
Latest reported$131.64Mperiod ending
Latest reported$131.64Mperiod ending
LGND TTM Cash from Operations (-$14.30M → $131.64M)
TTM operating cash flow (statement)
High-resolution chart · PNG
LGND operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -34,213,000 | |
| -46,634,000 | |
| -47,355,000 | |
| -48,405,000 | |
| -47,121,000 | |
| -52,363,000 | |
| -60,500,000 | |
| -66,800,000 | |
| -70,800,000 | |
| -68,500,000 | |
| -66,600,000 | |
| -37,100,000 | |
| -29,000,000 | |
| -25,300,000 | |
| -13,400,000 | |
| -32,700,000 | |
| -32,500,000 | |
| -33,300,000 | |
| -33,300,000 | |
| -31,500,000 | |
| -24,400,000 | |
| -19,800,000 | |
| -14,600,000 | |
| -14,400,000 | |
| -14,300,000 |